Bristol Myers details Krazati confirmatory study failure in colorectal cancer

July 6, 2026 10:59 AM EDT R&DPharma Bris­tol My­ers de­tails Kraza­ti con­fir­ma­to­ry study fail­ure in col­orec­tal can­cer Max Gelman Senior Editor While Amer­i­cans geared up for the Ju­ly 4 hol­i­day, Bris­tol My­ers Squibb laid out how a con­fir­ma­to­ry tri­al for its drug Kraza­ti failed in col­orec­tal … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER